Gomchok D, Ge R, Wuren T
Int J Mol Sci. 2023; 24(19).
PMID: 37834171
PMC: 10572297.
DOI: 10.3390/ijms241914724.
Chaiyabutr N, Chanhome L, Vasaruchapong T, Laoungbua P, Khow O, Rungsipipat A
Toxicon X. 2020; 7:100046.
PMID: 32875291
PMC: 7452022.
DOI: 10.1016/j.toxcx.2020.100046.
Lordan R, Tsoupras A, Zabetakis I, Demopoulos C
Molecules. 2019; 24(23).
PMID: 31816871
PMC: 6930554.
DOI: 10.3390/molecules24234414.
Tsoupras A, Lordan R, Zabetakis I
Nutrients. 2018; 10(5).
PMID: 29757226
PMC: 5986484.
DOI: 10.3390/nu10050604.
Scherlinger M, Sisirak V, Richez C, Lazaro E, Duffau P, Blanco P
Curr Rheumatol Rep. 2017; 19(8):48.
PMID: 28718063
DOI: 10.1007/s11926-017-0678-0.
Phospholipid derived mediators and glomerulonephritis.
Wardle E
Mediators Inflamm. 1993; 2(2):99-102.
PMID: 18475509
PMC: 2365393.
DOI: 10.1155/S0962935193000134.
Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity.
Rodriguez-Barbero A, Bosque E, Rivas-Cabaero L, Arevalo M, Lopez-Novoa J
Mediators Inflamm. 1992; 1(1):23-6.
PMID: 18475436
PMC: 2365312.
DOI: 10.1155/S096293519200005X.
Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.
Tsoupras A, Fragopoulou E, Nomikos T, Iatrou C, Antonopoulou S, Demopoulos C
Mediators Inflamm. 2007; 2007:27683.
PMID: 17710109
PMC: 1939920.
DOI: 10.1155/2007/27683.
Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells.
Fragopoulou E, Iatrou C, Demopoulos C
Mediators Inflamm. 2005; 2005(5):263-72.
PMID: 16258193
PMC: 1533888.
DOI: 10.1155/MI.2005.263.
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change.
Bussolati B, Mariano F, Biancone L, Foa R, David S, Cambi V
Am J Pathol. 1999; 154(2):623-32.
PMID: 10027419
PMC: 1849998.
DOI: 10.1016/S0002-9440(10)65307-2.
Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.
Juncos L, Ren Y, Arima S, Ito S
J Clin Invest. 1993; 91(4):1374-9.
PMID: 8473488
PMC: 288109.
DOI: 10.1172/JCI116339.
Role of platelets in progressive glomerular diseases.
Zoja C, Remuzzi G
Pediatr Nephrol. 1995; 9(4):495-502.
PMID: 7577419
DOI: 10.1007/BF00866739.
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response.
Makowka L, Miller C, Chapchap P, Podesta L, Pan C, Pressley D
Ann Surg. 1987; 206(4):482-95.
PMID: 3310931
PMC: 1493236.
DOI: 10.1097/00000658-198710000-00009.
Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells.
Neuwirth R, Singhal P, Diamond B, Hays R, Lobmeyer L, Clay K
J Clin Invest. 1988; 82(3):936-44.
PMID: 3166467
PMC: 303605.
DOI: 10.1172/JCI113701.
Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
Camussi G, Bussolino F, Salvidio G, Baglioni C
J Exp Med. 1987; 166(5):1390-404.
PMID: 3119758
PMC: 2189646.
DOI: 10.1084/jem.166.5.1390.
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases.
Camussi G, Tetta C, Bussolino F, Baglioni C
J Exp Med. 1988; 168(4):1293-306.
PMID: 3049910
PMC: 2189082.
DOI: 10.1084/jem.168.4.1293.
Synthesis of trideuterated O-alkyl platelet activating factor and lyso derivatives.
Prakash C, Saleh S, Taber D, Blair I
Lipids. 1989; 24(9):786-92.
PMID: 2586235
DOI: 10.1007/BF02544585.
The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor.
Kaminski D, ANDRUS C, German D, Deshpande Y
Ann Surg. 1990; 212(4):455-61.
PMID: 2171443
PMC: 1358278.
DOI: 10.1097/00000658-199010000-00008.
Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.
Camussi G, Tetta C, Bussolino F, Baglioni C
J Exp Med. 1990; 171(3):913-27.
PMID: 2137857
PMC: 2187779.
DOI: 10.1084/jem.171.3.913.
The role of platelet-activating factor (PAF) in experimental glomerular injury.
Ortiz A, Gomez-Chiarri M, Lerma J, Gonzalez E, Egido J
Lipids. 1991; 26(12):1310-5.
PMID: 1819722
DOI: 10.1007/BF02536555.
